Reviewed by Shameer Deen, ST5 Urology Registrar
Drug interactions remain one of the leading causes of preventable adverse drug events in clinical practice [1]. Whether you are a junior doctor writing your first prescription or a seasoned consultant managing complex polypharmacy, understanding the mechanisms behind drug interactions is essential for safe prescribing.
Types of Drug Interactions
1. Pharmacokinetic Interactions
These interactions affect how a drug is absorbed, distributed, metabolised, or excreted (ADME). The most clinically significant pharmacokinetic interactions involve the cytochrome P450 (CYP) enzyme system in the liver [3]. For example, CYP3A4 inhibitors such as ketoconazole can dramatically increase plasma levels of co-administered drugs like simvastatin, raising the risk of rhabdomyolysis.
Other important pharmacokinetic mechanisms include altered gastrointestinal absorption (e.g., antacids reducing the absorption of fluoroquinolones), competition for protein binding sites, and changes in renal clearance [2].
2. Pharmacodynamic Interactions
Pharmacodynamic interactions occur when two drugs act on the same receptor, signalling pathway, or physiological system. These can be additive, synergistic, or antagonistic [2]. A classic example is the combined use of ACE inhibitors and potassium-sparing diuretics, which can lead to dangerous hyperkalaemia through additive effects on potassium retention.
3. Pharmaceutical (Physicochemical) Interactions
Less commonly discussed but equally important, these interactions occur when drugs are physically incompatible before they even reach the patient. Intravenous drug admixture incompatibilities are a prime example, where combining certain infusions can cause precipitation or inactivation [1].
Risk Factors for Clinically Significant Interactions
Several patient-specific factors increase the risk of harm from drug interactions [2]:
- Polypharmacy — patients on five or more medications are at exponentially higher risk
- Hepatic or renal impairment — altered metabolism and clearance change drug levels unpredictably
- Extremes of age — neonates and elderly patients have reduced metabolic capacity
- Narrow therapeutic index drugs — warfarin, digoxin, lithium, and aminoglycosides are particularly dangerous
- Genetic polymorphisms — CYP2D6 poor metabolisers may experience toxicity at standard doses [3]
How MedNext Helps
MedNext Formulary includes a real-time drug interaction checker covering over 14,600 known interactions across our database of 2,866 drugs. When you select two or more drugs, the system cross-references them against the MedNext Audited Proprietary Dataset and returns severity-graded results — from minor interactions that may require monitoring to critical combinations that should be avoided entirely.
Unlike simple lookup tables, MedNext provides clinical context for each interaction, explaining the mechanism and suggesting management strategies. This means you can make informed decisions rather than simply receiving a "do not co-prescribe" warning.
Best Practice at the Point of Care
Always check interactions before prescribing, especially when adding a new drug to an existing regimen. Pay particular attention to narrow therapeutic index drugs, and remember that over-the-counter medications and herbal supplements can also cause significant interactions. With MedNext in your pocket, this check takes seconds rather than minutes.
References
- Baxter K, Preston CL (eds). Stockley's Drug Interactions. Pharmaceutical Press, 11th Edition, 2024.
- Cascorbi I. Drug Interactions—Principles, Examples and Clinical Consequences. Dtsch Arztebl Int. 2012;109(33-34):546-556.
- Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76(3):391-396.